ProQR Therapeutics (PRQR) Assets Average (2014 - 2026)

ProQR Therapeutics (PRQR) has reported Assets Average for 12 consecutive years, with $120.5 million the latest figure, recorded in Q1 2026.

• Quarterly Assets Average fell 33.74% year-over-year to $120.5 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $120.5 million (down 33.74% YoY) and the FY2025 annual result came in at $159.7 million, down 8.22% from the prior year.
• Assets Average declined to $120.5 million in Q1 2026 per PRQR's latest filing, from $134.9 million in the prior quarter.
• Over the last five years, Assets Average for PRQR reached as high as $227.5 million in Q1 2022 and fell as low as $120.5 million in Q1 2026.
• A 5-year average of $163.7 million and a median of $164.6 million in 2025 frame the typical range for Assets Average.
• Annual changes were most pronounced in 2022 — Assets Average tumbled 99.6% — and 2025, when it advanced 22.11%.
• Year by year, Assets Average stood at $166.7 million in 2022, then retreated by 4.48% to $159.3 million in 2023, then retreated by 1.82% to $156.4 million in 2024, then decreased by 13.72% to $134.9 million in 2025, then fell by 10.68% to $120.5 million in 2026.
• According to Business Quant data, Assets Average over the past three periods registered $120.5 million, $134.9 million, and $149.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.